Bluejay Diagnostics (BJDX) Change in Account Payables (2022 - 2023)
Historic Change in Account Payables for Bluejay Diagnostics (BJDX) over the last 2 years, with Q4 2023 value amounting to -$254369.0.
- Bluejay Diagnostics' Change in Account Payables fell 16694.84% to -$254369.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$235760.0, marking a year-over-year decrease of 17888.09%. This contributed to the annual value of -$346352.0 for FY2024, which is 4690.87% down from last year.
- According to the latest figures from Q4 2023, Bluejay Diagnostics' Change in Account Payables is -$254369.0, which was down 16694.84% from $448199.0 recorded in Q3 2023.
- Bluejay Diagnostics' Change in Account Payables' 5-year high stood at $448199.0 during Q3 2023, with a 5-year trough of -$520728.0 in Q2 2022.